Abstract
The epidemiology of Clostridium difficile infection (CDI) among oncology inpatients is poorly understood. In multivariate analysis we identified age, history of CDI, and prior receipt of cephalosporins, β-lactam/β-lactamase inhibitors, metronidazole, and blood transfusion as risk factors associated with CDI. Reducing broad-spectrum antibiotic use, particularly among older patients and those with a CDI history and recent blood transfusions, may decrease CDI risk in this population.
| Original language | English |
|---|---|
| Pages (from-to) | 1408-1410 |
| Number of pages | 3 |
| Journal | American Journal of Infection Control |
| Volume | 44 |
| Issue number | 11 |
| DOIs | |
| State | Published - 1 Nov 2016 |
| Externally published | Yes |
Keywords
- Clostridium difficile
- epidemiology
- oncology